These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6440325)

  • 1. A study of the relationship between the resistance of Mycobacterium tuberculosis to isonicotinic acid hydrazide (isoniazid) and to thiophen-2-carboxylic acid hydrazide.
    Yates MD; Grange JM; Collins CH
    Tubercle; 1984 Dec; 65(4):295-9. PubMed ID: 6440325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A katG S315T or an ahpC promoter mutation mediate Mycobacterium tuberculosis resistance to 2-thiophen carboxylic acid hydrazide, an inhibitor resembling the anti-tubercular drugs Isoniazid and Ethionamide.
    Franceschelli JJ; Belardinelli JM; Tong P; Loftus B; Recio-Balsells A; Labadié GR; Gordon SV; Morbidoni HR
    Tuberculosis (Edinb); 2018 Sep; 112():69-78. PubMed ID: 30205971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiometric studies on the use of selective inhibitors in the identification of Mycobacterium spp.
    Collins T; Levett PN
    J Med Microbiol; 1989 Nov; 30(3):175-81. PubMed ID: 2511320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the reliability of thiophen-2-carboxylic acid hydrazine result for the identification of Mycobacterium bovis].
    Jiang GL; Liang Q; Fu YH; Dong LL; Zhao YL; Huang HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):360-2. PubMed ID: 24047811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Classical" and "Asian" variants of Mycobacterium tuberculosis isolated in South East England 1977-1980.
    Yates MD; Collins CH; Grange JM
    Tubercle; 1982 Mar; 63(1):55-61. PubMed ID: 6805116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid.
    Zhang Y; Dhandayuthapani S; Deretic V
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13212-6. PubMed ID: 8917570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential identification of mycobacteria. 3. Use of thiacetazone, thiophen-2-carboxylic acid hydrazide, and triphenyltetrazolium chloride.
    Vestal AL; Kubica GP
    Scand J Respir Dis; 1967; 48(2):142-8. PubMed ID: 4168884
    [No Abstract]   [Full Text] [Related]  

  • 8. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.
    Banerjee A; Dubnau E; Quemard A; Balasubramanian V; Um KS; Wilson T; Collins D; de Lisle G; Jacobs WR
    Science; 1994 Jan; 263(5144):227-30. PubMed ID: 8284673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies on the influence of dimethylsulfoxide (DMSO) on reversion to sensitivity to isonicotinic acid hydrazide (INH) and rifampicin (RMP) in resistant strains of tubercle bacilli.
    Szydłowska T; Pawłowska I
    Arch Immunol Ther Exp (Warsz); 1976; 24(4):575-7. PubMed ID: 826230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis.
    Rouse DA; Morris SL
    Infect Immun; 1995 Apr; 63(4):1427-33. PubMed ID: 7890405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis.
    Dhandayuthapani S; Zhang Y; Mudd MH; Deretic V
    J Bacteriol; 1996 Jun; 178(12):3641-9. PubMed ID: 8655566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spectrographic study of tubercle bacilli sensitive and resistant to isonicotinic acid hydrazide (INH) and of some other mycobacteria].
    Andrejew A
    Ann Inst Pasteur (Paris); 1967 May; 112(5):652-6. PubMed ID: 4964298
    [No Abstract]   [Full Text] [Related]  

  • 13. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
    Larsen MH; Vilchèze C; Kremer L; Besra GS; Parsons L; Salfinger M; Heifets L; Hazbon MH; Alland D; Sacchettini JC; Jacobs WR
    Mol Microbiol; 2002 Oct; 46(2):453-66. PubMed ID: 12406221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of tubercle bacilli.
    Yates MD; Collins CH
    Ann Microbiol (Paris); 1979 Jul; 130B(1):13-9. PubMed ID: 389130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.
    Zhang Y; Heym B; Allen B; Young D; Cole S
    Nature; 1992 Aug; 358(6387):591-3. PubMed ID: 1501713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taxonomic studies on the Mycobacterium tuberculosis series.
    Tsukamura M; Mizuno S; Toyama H
    Microbiol Immunol; 1985; 29(4):285-99. PubMed ID: 3927118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the problem of differentiation of human and bovine tubercle bacteria with the aid of thiophene-2-carboxylic acid hydrazide (TCH) according to Boenicke].
    DISSMANN E; ZECHNER E
    Z Hyg Infektionskr; 1960; 146():210-4. PubMed ID: 13816935
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel isoniazid derivative as promising antituberculosis agent.
    Volynets GP; Tukalo MA; Bdzhola VG; Derkach NM; Gumeniuk MI; Tarnavskiy SS; Yarmoluk SM
    Future Microbiol; 2020 Jul; 15(10):869-879. PubMed ID: 32662670
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands.
    van Soolingen D; de Haas PE; van Doorn HR; Kuijper E; Rinder H; Borgdorff MW
    J Infect Dis; 2000 Dec; 182(6):1788-90. PubMed ID: 11069256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on
    Zomorodbakhsh S; Abbasian Y; Naghinejad M; Sheikhpour M
    Int J Nanomedicine; 2020; 15():5901-5909. PubMed ID: 32884258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.